Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

The Effect of Diagnostic Wait Time on the Survival of Patients with Diffuse Large B-Cell Lymphoma Differs Depending on International Prognostic Index

Shin Lee, MD, Negoro Eiju, Morishita Tetsuji, MD PhD, Kei Fujita, MD, Hideaki Yamauchi, MD, Kana Oiwa, MD, Takanori Ueda, MD PhD, Takahiro Yamauchi, MD PhD

Blood (2019) 134 (Supplement_1): 2902.

https://doi.org/10.1182/blood-2019-121527

Published: 2019

Journal Articles

Pralatrexate-Resistant Cell Lines Show Intact Internalization Via RFC1 but Collateral Sensitivity to Nucleoside Analogs

Kana Oiwa, MD, Naoko Hosono, MD, Rie Nishi, PhD, Takanori Ueda, MD PhD, Luigi Scott, PhD, Owen A. O'Connor, MD, PhD, Takahiro Yamauchi, MD PhD

Blood (2018) 132 (Supplement 1): 3961.

https://doi.org/10.1182/blood-2018-99-110147

Published: 2018

Journal Articles

YM155 Exerts Potent Cytotoxic Activity Against Quiescent (G0/G1) Multiple Myeloma and Bortezomib Resistant Cells Via Inhibition of Mcl-1 and Survivin

Miyuki Ookura, MD, Tatsuya Fujii, Shinji Kishi, MD PhD, Hiroko Shigemi, MDPhD, Naoko Hosono, MDPhD, Takahiro Yamauchi, MD PhD, Takanori Ueda, MD PhD, Akira Yoshida, MD PhD

Blood (2015) 126 (23): 3023.

https://doi.org/10.1182/blood.V126.23.3023.3023

Published: 2015

Journal Articles

Decitabine Induced the Cell Differentiation, Decreased Malignant Potential, and Increased Susceptibility to Apoptosis Via a Death Receptor Pathway with Hypomethylation of MS4A3, PAR-4, APITD1, LOX in Myelodysplastic Syndrome Cell Line, MDS-L

Rie Nishi, Takahiro Yamauchi, MD PhD, Miyuki Ookura, MD, Yasufumi Matsuda, MD, Toshiki Tasaki, MD, Kaoru Tohyama, MD PhD, Takanori Ueda, MD PhD

Blood (2014) 124 (21): 4599.

https://doi.org/10.1182/blood.V124.21.4599.4599

Published: 2014

Journal Articles

Synergistic Cytotoxicity Between Panobinostat and Ponatinib In Imatinib-Resistant Chronic Myeloid Leukemia Cells

Yasufumi Matsuda, MD, Takahiro Yamauchi, MD, PhD, Kanako Uzui, Eiju Negoro, MD, Koji Morinaga, MD., PhD., Hiroko Shigemi, MD, Rie Nishi, Shinya Kimura, MD, PhD, Taira Maekawa, MD, PhD, Takanori Ueda, MD, PhD

Blood (2013) 122 (21): 3989.

https://doi.org/10.1182/blood.V122.21.3989.3989

Published: 2013

Journal Articles

Go6976, a Potent FLT3 Kinase Inhibitor, Exerts Antiproliferative Activity Against Acute Myeloid Leukemia Via Inhibition Of Survivin and Mcl-1 In The Presence Of Human Serum

Akira Yoshida, MD, PhD, Kouichi Zokumasu, Takanori Ueda, MD, PhD

Blood (2013) 122 (21): 3839.

https://doi.org/10.1182/blood.V122.21.3839.3839

Published: 2013

Journal Articles

Establishment of Novel Leukemic Cell Lines Resistant to Clofarabine by Dual Mechanisms of Decreased Active Metabolite and Increased Antiapoptotic Factor

Hiroko Shigemi, MD, Takahiro Yamauchi, MD, PhD, Takanori Ueda, MD, PhD

Blood (2012) 120 (21): 1356.

https://doi.org/10.1182/blood.V120.21.1356.1356

Published: 2012

Journal Articles

Early Diagnosis and Successful Treatment of Idiopathic Autoimmune Factor XIII Deficiency Complicated by Intracerebral Hemorrhage

Mihoko Takai, MD, Naoko Hosono, MD., PhD., Shinji Kishi, MD, PhD, Takahiro Yamauchi, MD, PhD, Yoshimasa Urasaki, MD, PhD, Hiroyuki Neishi, MD, Hiroaki Takeuchi, MD, PhD, Masaharu Souri, PhD, Ken-ichiro Kikuta, MD, PhD, Toshihiro Haba, MD., PhD., Akitada Ichinose, MD, PhD, Takanori Ueda, MD, PhD

Blood (2012) 120 (21): 4634.

https://doi.org/10.1182/blood.V120.21.4634.4634

Published: 2012

Journal Articles

Marked Upregulations of Survivin and Aurora-B Kinase Are Associated with Disease Progression in the Myelodysplastic Syndromes,

Akira Yoshida, MD, PhD, Kouichi Zokumasu, Takahiro Yamauchi, MD, PhD, Kazutaka Takagi, MD, PhD, Shinji Kishi, MD, PhD, Yoshimasa Urasaki, MD, PhD, Kaoru Tohyama, MD, PhD, Takanori Ueda, MD, PhD

Blood (2011) 118 (21): 3823.

https://doi.org/10.1182/blood.V118.21.3823.3823

Published: 2011

Journal Articles

Whole-Body Diffusion-Weighted Magnetic Resonance Imaging Is a New Sensitive Non-Invasive Method for Staging and Monitoring Chemotherapy Response of Malignant Lymphoma Including Indolent Lymphoma Compared with FDG-PET/CT

Shinji Kishi, MD, PhD, Tatsuro Tsuchida, MD, PhD, Takahiro Yamauchi, MD, PhD, Naoko Hosono, MD, PhD, Satoshi Ikegaya, MD, PhD, Yoshimasa Urasaki, MD, PhD, Hidehiko Okazawa, MD, PhD, Hirohiko Kimura, MD, PhD, Takanori Ueda, MD, PhD

Blood (2010) 116 (21): 4147.

https://doi.org/10.1182/blood.V116.21.4147.4147

Published: 2010

Journal Articles

Prominent Elevation of Survivin Expression in High-Risk Myelodysplastic Syndrome.

Akira Yoshida, MD, PhD, Saki Tanaka, Takahiro Yamauchi, Kazutaka Takagi, Shinji Kishi, MD, PhD, Yoshimasa Urasaki, MD, PhD, Kaoru Tohyama, Takanori Ueda, MD, PhD

Blood (2009) 114 (22): 4842.

https://doi.org/10.1182/blood.V114.22.4842.4842

Published: 2009

Journal Articles

Utility of PCR Amplification and DNA Microarray Hybridization in 16S rDNA for Rapid Diagnosis of Bacteremia Associated with Hematological Malignancies.

Eiju Negoro, Hiromichi Iwasaki, MD, PhD, Katunori Tai, Satoshi Ikegaya, Mitsunobu Shimadzu, Ph.D., Takanori Ueda, MD, PhD

Blood (2009) 114 (22): 1635.

https://doi.org/10.1182/blood.V114.22.1635.1635

Published: 2009

Journal Articles

Unique Pharmacokinetic Self-Potentiation of Idarubicin through Induction of Carbonyl Reducing Enzymes in Contrast to Other Anthracyclines, Pharmacologic and Clinical Study

Shinji Kishi, MD, PhD, Taro Yamashita, MD, PhD, Toshihiro Fukushima, MD, PhD, Yoshimasa Urasaki, MD, PhD, Tamami Seo, MD, PhD, Toru Nakamura, MD, PhD, Toshihiro Haba, MD, PhD, Ken-ichi Kamiya, MD, PhD, Jun Murakami, MD, PhD, Mikio Ueda, MD, PhD, Shinji Nakao, MD, PhD, Takanori Ueda, MD, PhD

Blood (2008) 112 (11): 4025.

https://doi.org/10.1182/blood.V112.11.4025.4025

Published: 2008

Journal Articles

Monosodium Urate Crystals Bind with Idiotype Protein and Promote Dendritic Cells to Induce Cytotoxic T Cells in Vitro

Ippei Sakamaki, MD, Kunihiro Inai, MD, PhD, Takanori Ueda, MD, PhD, Hiroshi Tsutani, MD, PhD

Blood (2008) 112 (11): 4904.

https://doi.org/10.1182/blood.V112.11.4904.4904

Published: 2008

Journal Articles

Unique Resistance Mechanism to Dexamethasone by Glutathione S-Transferase M1 Involving p38 MAPK and NF-κB Pathways, Possible Prognostic Role for Childhood ALL.

Naoko Hosono, MD, Shinji Kishi, MD., PhD., Sumiko Iho, PhD., Yoshimasa Urasaki, MD., PhD., Akira Yoshida, MD., PhD., Hisanori Kurooka, PhD., Yoshifumi Yokota, MD., PhD., Takanori Ueda, MD., PhD.

Blood (2007) 110 (11): 2375.

https://doi.org/10.1182/blood.V110.11.2375.2375

Published: 2007

Journal Articles

Anti-Tumor Effect of INNO-406, a Novel Bcr-Abl Inhibitor in Combination with Cyclosporin A Against the Murine Central Nervous System and Systemic Leukemia Model.

Asumi Yokota, Shinya Kimura, Satohiro Masuda, Eishi Ashihara, Yoshimasa Urasaki, Yasuhito Terui, Martin Ruthardt, Takanori Ueda, Kiyohiko Hatake, Ken-ichi Inui, Taira Maekawa

Blood (2007) 110 (11): 1598.

https://doi.org/10.1182/blood.V110.11.1598.1598

Published: 2007

Journal Articles

Monosodium Urate Crystal as a Carrier for Idiotype Tumor Vaccine.

Ippei Sakamaki, MD, Kunihiro Inai, MD PhD, Takanori Ueda, MD PhD, Hiroshi Tsutani, MD PhD

Blood (2007) 110 (11): 4893.

https://doi.org/10.1182/blood.V110.11.4893.4893

Published: 2007

Journal Articles

Cyclosporin A, a P-gp Inhibitor, Augments the Anti-Central Nervous System Ph + Leukemia Effects of INNO-406.

Asumi Yokota, Shinya Kimura, Satohiro Masuda, Eishi Ashihara, Yoshimasa Urasaki, Yasuhito Terui, Martin Ruthardt, Takanori Ueda, Kiyohiko Hatake, Ken-ichi Inui, Taira Maekawa

Blood (2006) 108 (11): 834.

https://doi.org/10.1182/blood.V108.11.834.834

Published: 2006

Journal Articles

INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph + leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity

Asumi Yokota, Shinya Kimura, Satohiro Masuda, Eishi Ashihara, Junya Kuroda, Kiyoshi Sato, Yuri Kamitsuji, Eri Kawata, Yasuyuki Deguchi, Yoshimasa Urasaki, Yasuhito Terui, Martin Ruthardt, Takanori Ueda, Kiyohiko Hatake, Ken-ichi Inui, Taira Maekawa

Blood (2006) 109 (1): 306–314.

https://doi.org/10.1182/blood-2006-03-013250

Published: 2006

Includes: Supplemental data

Journal Articles

Anti-Tumor Activity of a Novel Bcr-Abl/Lyn Dual Inhibitor, NS-187, in Murine CNS Ph + Leukemia Models.

Asumi Yokota, Shinya Kimura, MD, Tatsuya Oyama, Eishi Ashihara, MD, Haruna Naito, PhD, Yoshimasa Urasaki, MD, Takanori Ueda, MD, Yasuhito Terui, MD, Kiyohiko Hatake, MD, Kazuko Hirabayashi, PhD, Taira Maekawa, MD

Blood (2005) 106 (11): 493.

https://doi.org/10.1182/blood.V106.11.493.493

Published: 2005

NARROW

The Effect of Diagnostic Wait Time on the Survival of Patients with Diffuse Large B-Cell Lymphoma Differs Depending on International Prognostic Index

Pralatrexate-Resistant Cell Lines Show Intact Internalization Via RFC1 but Collateral Sensitivity to Nucleoside Analogs

YM155 Exerts Potent Cytotoxic Activity Against Quiescent (G0/G1) Multiple Myeloma and Bortezomib Resistant Cells Via Inhibition of Mcl-1 and Survivin

Decitabine Induced the Cell Differentiation, Decreased Malignant Potential, and Increased Susceptibility to Apoptosis Via a Death Receptor Pathway with Hypomethylation of MS4A3, PAR-4, APITD1, LOX in Myelodysplastic Syndrome Cell Line, MDS-L

Synergistic Cytotoxicity Between Panobinostat and Ponatinib In Imatinib-Resistant Chronic Myeloid Leukemia Cells

Go6976, a Potent FLT3 Kinase Inhibitor, Exerts Antiproliferative Activity Against Acute Myeloid Leukemia Via Inhibition Of Survivin and Mcl-1 In The Presence Of Human Serum

Establishment of Novel Leukemic Cell Lines Resistant to Clofarabine by Dual Mechanisms of Decreased Active Metabolite and Increased Antiapoptotic Factor

Early Diagnosis and Successful Treatment of Idiopathic Autoimmune Factor XIII Deficiency Complicated by Intracerebral Hemorrhage

Marked Upregulations of Survivin and Aurora-B Kinase Are Associated with Disease Progression in the Myelodysplastic Syndromes,

Whole-Body Diffusion-Weighted Magnetic Resonance Imaging Is a New Sensitive Non-Invasive Method for Staging and Monitoring Chemotherapy Response of Malignant Lymphoma Including Indolent Lymphoma Compared with FDG-PET/CT

Prominent Elevation of Survivin Expression in High-Risk Myelodysplastic Syndrome.

Utility of PCR Amplification and DNA Microarray Hybridization in 16S rDNA for Rapid Diagnosis of Bacteremia Associated with Hematological Malignancies.

Unique Pharmacokinetic Self-Potentiation of Idarubicin through Induction of Carbonyl Reducing Enzymes in Contrast to Other Anthracyclines, Pharmacologic and Clinical Study

Monosodium Urate Crystals Bind with Idiotype Protein and Promote Dendritic Cells to Induce Cytotoxic T Cells in Vitro

Unique Resistance Mechanism to Dexamethasone by Glutathione S-Transferase M1 Involving p38 MAPK and NF-κB Pathways, Possible Prognostic Role for Childhood ALL.

Anti-Tumor Effect of INNO-406, a Novel Bcr-Abl Inhibitor in Combination with Cyclosporin A Against the Murine Central Nervous System and Systemic Leukemia Model.

Monosodium Urate Crystal as a Carrier for Idiotype Tumor Vaccine.

Cyclosporin A, a P-gp Inhibitor, Augments the Anti-Central Nervous System Ph + Leukemia Effects of INNO-406.

INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph + leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity

Anti-Tumor Activity of a Novel Bcr-Abl/Lyn Dual Inhibitor, NS-187, in Murine CNS Ph + Leukemia Models.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only